Skip to content
Abierto

Combined synopsis and solicitation

AXION BIOSYSTEMS MAESTRO PRO MICROELECTRODE ARRAY (MEA) SYSTEM – BRAND NAME OR EQUAL

CBER-2026-135659

Food and Drug Administration, Food and Drug Administration. Analytical Laboratory Instrument Manufacturing.

Offers due

September 16, 2026 at 9:00 AM EDT

That is today. Posted September 9, 2026.

Description

As published on SAM.gov.

This is a combined synopsis/solicitation for commercial products and commercial services prepared in accordance with Federal Acquisition Regulation (FAR) Part 12, as implemented through the Revolutionary FAR Overhaul (RFO) model deviation and applicable Department of Health and Human Services (HHS) class deviations. This announcement constitutes solicitation. Quotations are being requested, and a separate written solicitation will not be issued.

Solicitation No. CBER-2026-135659 is issued as a Request for Quotation (RFQ) for the purchase of an Axion BioSystems Maestro Pro Microelectrode Array (MEA) System, brand name or equal, together with the required software, consumables, installation, training, warranty, and an option for preventive maintenance. This acquisition is not set aside for small business concerns and is being competed on an unrestricted basis.

The Government intends to issue a Firm-Fixed-Price purchase order using simplified procedures for commercial products and commercial services under RFO FAR Part 12. Please refer to the Combined Synopsis-Solicitation Maestro Pro Microelectrode Array System Document and all the attachments for specfic details about the requirement

Publications

Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.

  1. September 9, 2026

    Combined synopsis and solicitation

    Due September 16, 2026 at 9:00 AM EDT. SAM.gov, notice 88d33786b3134105840ac538debe6393

Points of contact